Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo

Laboratory Investigation

Volumn 75, Issue 4, 1996, Pages 487-501

  Takeshita, Satoshi ^a   Tsurumi, Yukio ^a   Couffinahl, Thierry ^a   Asahara, Takayuki ^a   Bauters, Christophe ^a   Symes, James ^a   Ferrara, Napoleone ^b   Isner, Jeffrey M ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DNA TRANSFER; GENE TRANSFER; GENETIC TRANSFECTION; HISTOLOGY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIES; BLOOD PRESSURE; COLLATERAL CIRCULATION; DNA; ENDOTHELIAL GROWTH FACTORS; GENE TRANSFER TECHNIQUES; HINDLIMB; ISCHEMIA; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; RABBITS; REGIONAL BLOOD FLOW; TRANSFECTION; ULTRASONOGRAPHY, DOPPLER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029958320     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen JE, Aiello LM, Ferrara N, and King GL (1994). Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
2. Asahara T, Bauters C, Pastore CJ, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, and Isner JM (1995a). Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91:2793-2801.
3. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, and Ferrara N (1995b). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92:II-365-II-371.
4. 165. Circulation.
5. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, and Friedmann P (1992). Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor. J Vasc Surg 16:181-191.
6. Banai S, Jaklitsch MT, Casscells W, Shou M, Shrivastav S, Correa R, Epstein SE, and Unger EF (1991). Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 69:76-85.
7. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, and Unger EF (1994). Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183-2189.
8. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, and Isner JM (1994). Physiologic assessment of angiogenesis induced by vascular endothelial growth factor in a rabbit ischemic hindlimb model. Am J Physiol 36:H1263-H1271.
9. Bonnerot C, Rocancourt D, Briand P, Grimber G (1987). A b-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci USA 84:6795-6799.
10. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, and Isner JM (1996). Hypoxia-induced paracrine regulation of VEGF receptor expression. J Clin Invest 97:469-476.
11. Brown LF, Yeo K-T, Berse B, Yeo T-K, Senger DR, Dvorak HF, and van de Water L (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-1379.
12. Chapman GD, Lim CS, Gammon RS, Culp SC, Desper JS, Bauman RP, Swain JL, and Stack RS (1992). Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res 71:27-33.
13. Clowes AW, Reidy MA, and Clowes MM (1983). Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49:327-333.
14. Detmar M, Brown LF, Claffey KP, Yeo K-T, Kocher O, Jackman RW, Berse B, and Dvorak HF (1994). Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146.
15. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, and Segal J (1992). Validation of a Doppler wire for intravascular measurements of coronary artery flow velocity. Circulation 85:1899-1911.
16. Dvorak HF, Brown LF, Detmar M, and Dvorak AM (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039.
17. European Working Group on Critical Leg Ischemia (1991). Second European consensus document on chronic critical leg ischemia. Circulation 84:IV-1-IV-26.
18. Feldman LJ, Steg PG, Zheng LP, Chen D, Kearney M, McGarr SE, Barry JJ, Dedieu JF, Perricaudet M, and Isner JM (1995). Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest 95:2662-2671.
19. Ferrara N and Henzel WJ (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-855.
20. Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller GA, and Levinson AD (1993). Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 91:160-170.
21. Folkman J (1995). Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763.
22. 121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 271:5519-5523.
23. Horowitz J, Hariawala M, Sheriff DD, Keyt B, and Symes JF (1995). In vivo administration of vascular endothelial growth factor is associated with EDRF-dependent systemic hypotension in porcine and rabbit animal models (abstract). Circulation 92:I-630-I-631.
24. Houck KA, Leung DW, Rowland AM, Winer J, and Ferrara N (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037.
25. 165. Lancet 348:370-374.
26. Isner JM, Walsh K, Symes JF, Piezcek A, Takeshita S, Lowry J, Rossow S, Rosenfield K, Weir L, Brogi E, and Jurayj D (1995). Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 91:2687-2692.
27. Isner JM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, Rosenfiled K, Weir R, Brogi E, and Jurayj D (1996b). Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther 7:959-988.
28. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, and Connolly DT (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312.
29. Keyt BA, Nguyen HV, Berleau LT, Durate CM, Park J, Chen H, and Ferrara N (1996). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J Biol Chem 271:5638-5646.
30. Lemarchand P, Jones M, Yamada I, and Crystal RG (1993). In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 72:1132-1138.
31. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
32. Losordo DW, Pickering JG, Takeshita S, Leclerc G, Gal D, Weir L, Kearney M, Jekanowski J, and Isner JM (1994). Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 89:785-792.
33. McDonnell WM and Askari FK (1996). DNA vaccines. N Engl J Med 334:42-45.
34. Miles AA and Miles EM (1952). Vascular reactions to histamine, histamine liberators or leukotoxins in the skin of the guinea pig. J Physiol 118:228-257.
35. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, and Ulrich A (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
36. Nabel G (1994). Proposed amendment to Appendix D of the NIH Guidelines Regarding a Human Gene Therapy Protocol Entitled Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors. Hum Gene Ther 5:236-240.
37. Nabel EG, Gordon D, Yang Z-Y, Xu L, San H, Plautz GE, Wu, BY, Gao X, Huang L, and Nabel GJ (1992). Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization. Hum Gene Ther 3:649-656.
38. Park JE, Keller G-A, and Ferrara N (1993). The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial ECM and bioactivity of ECM-bound VEGF. Mol Biol Cell 4:1317-1326.
39. Pastore CJ, Isner JM, Bacha PA, Kearney M, Pickering JG (1995). Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo: Results of local versus systemic administration. Circ Res 77:519-529.
40. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladston SR, Freidman M, Sellke FW, and Simons M (1995). Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1:1085-1089.
41. Pepper MS and Montesano R (1990). Proteolytic balance and capillary morphogenesis. Cell Diff Dev 32:319-328.
42. Pickering JG, Weir L, Jekanowski J, Kearney MA, and Isner JM (1993). Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 91:1469-1480.
43. Plate KH, Breier G, Weich HA, Mennel HD, and Risau W (1994). Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors - Distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520-529.
44. Plouet J, Schilling J, and Gospodarowicz D (1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8:3801-3806.
45. Pu LQ, Jackson S, Lachapelle KJ, Arekat Z, Graham AM, Lisbona R, Brassard R, Carpenter S, and Symes JF (1994). A persistent hindlimb ischemia model in the rabbit. J Invest Surg 7:49-60.
46. Pu LQ, Sniderman AD, Brassard R, Lachapelle KJ, Graham AM, Lisbona R, and Symes JF (1993). Enhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation 88:208-215.
47. Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, and Isner JM (1993). Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther 4:749-758.
48. Ross R (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-805.
49. Takeshita S, Losordo DW, Kearney M, and Isner JM. (1994a). Time course of recombinant protein secretion following liposome-mediated gene transfer in a rabbit arterial organ culture model. Lab Invest 71:387-391.
50. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, and Isner JM (1995). Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 147:1649-1660.
51. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, and Isner JM (1994b). Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 93:662-670.
52. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, and Bohlen P (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586.
53. Tischer E, Mitchell R, Hartmann T, Silva M, Gospodarowicz D, Fiddes J, and Abraham JA (1991). The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954.
54. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, and Heldin C-H (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
55. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, and Felgner PL (1990). Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
56. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, and Ito H (1992). Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401-1403.
57. Yang R, Bunting S, Ko A, Keyt B, and Jin H (1995). Hemodynamic effects of vascular endothelial growth factor in conscious rats (abstract). Circulation 92:I-659.
58. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, and Wilson JM (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407-4411.
59. Ziada AM, Hudlicka O, Tyler KR, and Wright AJ (1984). The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 18:724-732.